ArticleJournal of immunology research2019

Promiscuous Chemokine Antagonist (BKT130) Suppresses Laser-Induced Choroidal Neovascularization by Inhibition of Monocyte Recruitment.

Shira Hagbi-Levi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.